Senior insider sale
Chief Executive Officer at PYXIS ONCOLOGY, INC. — senior position signals high conviction
$56.5K
24.92K shares
What this filing means
SULLIVAN LARA plans to sell 24.92K shares of PYXIS ONCOLOGY, INC. valued at approximately $56.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/12/2023ACC: 0001959173-23-003903
DirectorOfficer· Chief Executive Officer
Since Oct 2021
24.92K
Shares to sell
$56.5K
Approx. market value
4.92K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/31/2023
4.92KTotal acquired4.92K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2023 | Restricted Stock Vesting Compensation | 4.92K | — |
| Total | 4.92K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20K
Market value
$45.4K
9/11/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.92K
Market value
$11.1K
9/12/2023
Total
Units
24.92K
Value
$56.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/11/2023 | 20K | $45.4K | — | Completed |
| Planned — Approximate Date | ||||
9/12/2023 | 4.92K | $11.1K | NASDAQ | Planned |
| Total | 24.92K | $56.5K | ||